Europe & Central Asia (IDA & IBRD countries) vs Ireland: Domestic private health expenditure per capita, PPP

Europe & Central Asia (IDA & IBRD countries)
706.3 current international $
in 2023
Ireland
1,936 current international $
in 2023
Europe & Central Asia (IDA & IBRD countries) rank
13th
Ireland rank
12th

Domestic private health expenditure per capita, PPP over time

  • Europe & Central Asia (IDA & IBRD countries)
  • Ireland
05001.0k1.5k2.0k200020112023

How they compare

Ireland currently reports 1,936 current international $ against 706.3 current international $ in Europe & Central Asia (IDA & IBRD countries), a difference of 1,230 current international $.

That makes Ireland's figure about 2.7 times Europe & Central Asia (IDA & IBRD countries)'s.

Across all 24 years both countries report, Ireland has been ahead every year.

Europe & Central Asia (IDA & IBRD countries) ranks 13th and Ireland ranks 12th of 47 groups.

Ireland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Europe & Central Asia (IDA & IBRD countries) Ireland Difference Ahead
2000s 205.84 current international $ 651.63 current international $ 445.79 current international $ Ireland
2010s 391.38 current international $ 1,424 current international $ 1,032 current international $ Ireland
2020s 618 current international $ 1,797 current international $ 1,179 current international $ Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher domestic private health expenditure per capita, ppp, Europe & Central Asia (IDA & IBRD countries) or Ireland?
Ireland, at 1,936 current international $ against 706.3 current international $ in Europe & Central Asia (IDA & IBRD countries) as of 2023.
What is the difference in domestic private health expenditure per capita, ppp between Europe & Central Asia (IDA & IBRD countries) and Ireland?
1,230 current international $, with Ireland ahead.
How many years of comparable data are there for Europe & Central Asia (IDA & IBRD countries) and Ireland?
24 years are reported by both, from 2000 to 2023.
How do Europe & Central Asia (IDA & IBRD countries) and Ireland rank globally for domestic private health expenditure per capita, ppp?
Europe & Central Asia (IDA & IBRD countries) ranks 13th and Ireland ranks 12th of 47 groups.
Where does this data come from?
Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Domestic private health expenditure per capita, PPP (current international $). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia (IDA & IBRD countries) vs Ireland: Domestic private health expenditure per capita, PPP. Statizoid, drawing on Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/domestic-private-health-expenditure-per-capita-ppp-current-international/europe-and-central-asia-ida-and-ibrd-countries/ireland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/domestic-private-health-expenditure-per-capita-ppp-current-international/europe-and-central-asia-ida-and-ibrd-countries/ireland/">Europe & Central Asia (IDA & IBRD countries) vs Ireland: Domestic private health expenditure per capita, PPP</a> — Statizoid

About this data

Indicator
Domestic private health expenditure per capita, PPP (current international $)
Unit
current international $
Source
Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
240 places, 5,674 data points, 2000–2024
Last refreshed

Current private expenditures on health per capita expressed in international dollars at purchasing power parity.